GlassScriptPhysician profile
George D Laikos
NPI 1972562619
$676.22
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $207 · 2021: $42.56 · 2022: $18.35.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $120.95 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $111.84 | 2019-2020 | |
| Abbvie INC. | $105.00 | 2019-2022 | |
| Glaxosmithkline, LLC. | $86.03 | 2019-2020 | |
| Amgen INC. | $48.78 | 2019 | |
| Novo Nordisk INC | $34.55 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.24 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $28.32 | 2019 | |
| Ucb, INC. | $18.68 | 2019 | |
| Dynavax Technologies Corporation | $18.19 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $17.30 | 2020 | |
| Allergan, INC. | $15.50 | 2020 | |
| Mylan Specialty L.P. | $14.73 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.13 | 2019 | |
| Merck Sharp & Dohme LLC | $10.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Laikos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.